| 0 |
MESENTERIC CYST |
1 |
0.0769 |
| 1 |
CORNEAL LACERATION |
1 |
0.0556 |
| 2 |
BILIARY HAMARTOMA |
1 |
0.0526 |
| 3 |
IRIS DISCOLOURATION |
2 |
0.0435 |
| 4 |
GIANT PAPILLARY CONJUNCTIVITIS |
2 |
0.0400 |
| 5 |
TEAR DISCOLOURATION |
1 |
0.0222 |
| 6 |
EYELASH INJURY |
1 |
0.0200 |
| 7 |
EYELID RETRACTION |
2 |
0.0200 |
| 8 |
BENIGN NEOPLASM OF EYE |
1 |
0.0200 |
| 9 |
EYELID FUNCTION DISORDER |
15 |
0.0190 |
| 10 |
ARCUS LIPOIDES |
1 |
0.0159 |
| 11 |
CONJUNCTIVAL CYST |
1 |
0.0156 |
| 12 |
DEAFNESS PERMANENT |
3 |
0.0153 |
| 13 |
EYELID DISORDER |
33 |
0.0143 |
| 14 |
SWELLING OF EYELID |
88 |
0.0140 |
| 15 |
VASCULAR CAUTERISATION |
1 |
0.0132 |
| 16 |
CORNEAL IRRITATION |
1 |
0.0125 |
| 17 |
SCLERAL OEDEMA |
1 |
0.0120 |
| 18 |
EYELID CYST |
3 |
0.0116 |
| 19 |
MANDIBULAR MASS |
1 |
0.0114 |
| 20 |
VITAMIN K DECREASED |
1 |
0.0106 |
| 21 |
VITREORETINAL TRACTION SYNDROME |
1 |
0.0105 |
| 22 |
EYELID PAIN |
21 |
0.0103 |
| 23 |
EYELID SENSORY DISORDER |
2 |
0.0102 |
| 24 |
MYDRIASIS |
130 |
0.0101 |
| 25 |
EAR LOBE INFECTION |
1 |
0.0098 |
| 26 |
PERIORBITAL PAIN |
8 |
0.0094 |
| 27 |
SWOLLEN TEAR DUCT |
1 |
0.0094 |
| 28 |
EYELID IRRITATION |
23 |
0.0092 |
| 29 |
HYPERTROPHY OF TONGUE PAPILLAE |
1 |
0.0083 |
| 30 |
CONJUNCTIVAL DISCOLOURATION |
1 |
0.0082 |
| 31 |
INFUSION SITE SCAB |
1 |
0.0081 |
| 32 |
ANTI-THYROID ANTIBODY INCREASED |
1 |
0.0079 |
| 33 |
AUTOIMMUNE NEUROPATHY |
1 |
0.0078 |
| 34 |
QUADRANTANOPIA |
1 |
0.0076 |
| 35 |
INSTILLATION SITE DISCOMFORT |
1 |
0.0075 |
| 36 |
DEVICE COLOUR ISSUE |
3 |
0.0074 |
| 37 |
EPIRETINAL MEMBRANE |
2 |
0.0072 |
| 38 |
INSTILLATION SITE FOREIGN BODY SENSATION |
1 |
0.0069 |
| 39 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
38 |
0.0068 |
| 40 |
THERAPEUTIC PRODUCT EFFECT PROLONGED |
3 |
0.0066 |
| 41 |
ABNORMAL SENSATION IN EYE |
28 |
0.0065 |
| 42 |
ERYTHEMA OF EYELID |
35 |
0.0065 |
| 43 |
CONTACT LENS INTOLERANCE |
1 |
0.0064 |
| 44 |
NONINFECTIVE SIALOADENITIS |
1 |
0.0063 |
| 45 |
CHALAZION |
4 |
0.0062 |
| 46 |
SCLERAL DISCOLOURATION |
4 |
0.0061 |
| 47 |
VITREOUS DEGENERATION |
1 |
0.0061 |
| 48 |
DOSING ERROR |
1 |
0.0060 |
| 49 |
EYELID INJURY |
1 |
0.0057 |
| 50 |
EYELASH CHANGES |
1 |
0.0056 |
| 51 |
FOREIGN BODY SENSATION IN EYES |
35 |
0.0055 |
| 52 |
OCULAR HYPERAEMIA |
257 |
0.0054 |
| 53 |
CORNEAL REFLEX DECREASED |
2 |
0.0053 |
| 54 |
HALO VISION |
6 |
0.0053 |
| 55 |
SIGHT DISABILITY |
1 |
0.0053 |
| 56 |
ASTHENOPIA |
28 |
0.0051 |
| 57 |
EYELID EXFOLIATION |
4 |
0.0051 |
| 58 |
RETINAL ANEURYSM |
1 |
0.0050 |
| 59 |
EYELID MARGIN CRUSTING |
14 |
0.0048 |
| 60 |
EYE IRRITATION |
276 |
0.0048 |
| 61 |
HORDEOLUM |
20 |
0.0046 |
| 62 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
28 |
0.0045 |
| 63 |
BLEPHARITIS |
18 |
0.0045 |
| 64 |
EYELID SKIN DRYNESS |
5 |
0.0041 |
| 65 |
EXCESSIVE EYE BLINKING |
6 |
0.0041 |
| 66 |
OCULAR DISCOMFORT |
45 |
0.0040 |
| 67 |
KERATOMILEUSIS |
1 |
0.0039 |
| 68 |
INJURY CORNEAL |
2 |
0.0038 |
| 69 |
DRY EYE |
186 |
0.0037 |
| 70 |
EYE COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0037 |
| 71 |
PERIORBITAL SWELLING |
21 |
0.0037 |
| 72 |
SCLERAL DISORDER |
1 |
0.0037 |
| 73 |
BLEPHAROSPASM |
23 |
0.0036 |
| 74 |
INSTILLATION SITE PAIN |
9 |
0.0036 |
| 75 |
RETINAL OPERATION |
1 |
0.0036 |
| 76 |
EYE PRURITUS |
119 |
0.0035 |
| 77 |
HYPOAESTHESIA EYE |
2 |
0.0034 |
| 78 |
EYE DISCHARGE |
34 |
0.0033 |
| 79 |
EYE PAIN |
183 |
0.0032 |
| 80 |
INCREASED DOSE ADMINISTERED |
1 |
0.0032 |
| 81 |
PERIORAL DERMATITIS |
2 |
0.0031 |
| 82 |
LACRIMATION INCREASED |
90 |
0.0030 |
| 83 |
PERIORBITAL IRRITATION |
1 |
0.0029 |
| 84 |
EYELIDS PRURITUS |
9 |
0.0029 |
| 85 |
OPHTHALMIC MIGRAINE |
2 |
0.0029 |
| 86 |
CONJUNCTIVAL HAEMORRHAGE |
11 |
0.0029 |
| 87 |
GLASSY EYES |
2 |
0.0028 |
| 88 |
FACIAL DISCOMFORT |
2 |
0.0028 |
| 89 |
VITREOUS DETACHMENT |
6 |
0.0028 |
| 90 |
MILIA |
1 |
0.0028 |
| 91 |
ANISOCORIA |
1 |
0.0026 |
| 92 |
THERAPEUTIC PRODUCT EFFECT INCREASED |
3 |
0.0026 |
| 93 |
EYELID PTOSIS |
26 |
0.0026 |
| 94 |
CORNEAL TRANSPLANT |
2 |
0.0026 |
| 95 |
VISUAL BRIGHTNESS |
1 |
0.0025 |
| 96 |
DRUG EFFECT LESS THAN EXPECTED |
37 |
0.0025 |
| 97 |
LAGOPHTHALMOS |
1 |
0.0024 |
| 98 |
TRANSFERRIN SATURATION DECREASED |
1 |
0.0023 |
| 99 |
DACRYOSTENOSIS ACQUIRED |
3 |
0.0023 |
| 100 |
EYELID INFECTION |
1 |
0.0023 |
| 101 |
VISION BLURRED |
311 |
0.0023 |
| 102 |
PUNCTATE KERATITIS |
2 |
0.0022 |
| 103 |
EXTRAOCULAR MUSCLE PARESIS |
1 |
0.0022 |
| 104 |
METAMORPHOPSIA |
4 |
0.0022 |
| 105 |
SKIN INDENTATION |
1 |
0.0021 |
| 106 |
EYELID RASH |
2 |
0.0020 |
| 107 |
APPLICATION SITE ACNE |
1 |
0.0020 |
| 108 |
RETINAL TEAR |
5 |
0.0020 |
| 109 |
LENTIGO |
1 |
0.0020 |
| 110 |
CORNEAL SCAR |
1 |
0.0020 |
| 111 |
GLARE |
1 |
0.0019 |
| 112 |
PHOTOPHOBIA |
36 |
0.0019 |
| 113 |
EYELID OEDEMA |
22 |
0.0019 |
| 114 |
EYE SWELLING |
70 |
0.0019 |
| 115 |
SUPERFICIAL INJURY OF EYE |
2 |
0.0018 |
| 116 |
VITREOUS FLOATERS |
18 |
0.0018 |
| 117 |
EYE INFECTION BACTERIAL |
1 |
0.0018 |
| 118 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
6 |
0.0015 |
| 119 |
BROW PTOSIS |
1 |
0.0015 |
| 120 |
CATARACT NUCLEAR |
1 |
0.0015 |
| 121 |
TONGUE DRY |
2 |
0.0015 |
| 122 |
MIGRAINE WITH AURA |
4 |
0.0015 |
| 123 |
CORNEAL OPACITY |
2 |
0.0015 |
| 124 |
CUTANEOUS SYMPTOM |
1 |
0.0015 |
| 125 |
CORNEAL ABRASION |
2 |
0.0015 |
| 126 |
VITREOUS HAEMORRHAGE |
4 |
0.0014 |
| 127 |
INTRAOCULAR PRESSURE TEST ABNORMAL |
1 |
0.0014 |
| 128 |
EXOPHTHALMOS |
3 |
0.0014 |
| 129 |
EYE INFLAMMATION |
13 |
0.0014 |
| 130 |
DARK CIRCLES UNDER EYES |
2 |
0.0014 |
| 131 |
DRUG TOLERANCE INCREASED |
1 |
0.0013 |
| 132 |
PHOTOPSIA |
8 |
0.0013 |
| 133 |
GRANULOMA SKIN |
1 |
0.0012 |
| 134 |
DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT |
1 |
0.0012 |
| 135 |
DYSCHROMATOPSIA |
1 |
0.0012 |
| 136 |
ENDOCRINE OPHTHALMOPATHY |
1 |
0.0012 |
| 137 |
EYE INFECTION |
13 |
0.0012 |
| 138 |
INTESTINAL INFARCTION |
1 |
0.0011 |
| 139 |
CERUMEN IMPACTION |
1 |
0.0011 |
| 140 |
PARANASAL SINUS DISCOMFORT |
4 |
0.0011 |
| 141 |
PRODUCT AFTER TASTE |
1 |
0.0010 |
| 142 |
ANTINUCLEAR ANTIBODY INCREASED |
1 |
0.0010 |
| 143 |
TELANGIECTASIA |
1 |
0.0010 |
| 144 |
CONJUNCTIVAL OEDEMA |
1 |
0.0010 |
| 145 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
43 |
0.0010 |
| 146 |
PRODUCT ADMINISTRATION ERROR |
19 |
0.0009 |
| 147 |
DRY AGE-RELATED MACULAR DEGENERATION |
1 |
0.0009 |
| 148 |
FACIAL SPASM |
1 |
0.0009 |
| 149 |
CORNEAL OEDEMA |
2 |
0.0009 |
| 150 |
PUPILS UNEQUAL |
1 |
0.0009 |
| 151 |
CARBON DIOXIDE DECREASED |
1 |
0.0009 |
| 152 |
CHEMICAL BURN |
1 |
0.0009 |
| 153 |
APPLICATION SITE DISCHARGE |
1 |
0.0009 |
| 154 |
AORTIC VALVE REPLACEMENT |
1 |
0.0008 |
| 155 |
PRODUCT USED FOR UNKNOWN INDICATION |
1 |
0.0008 |
| 156 |
INTESTINAL DILATATION |
1 |
0.0007 |
| 157 |
MACULAR HOLE |
1 |
0.0007 |
| 158 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
1 |
0.0007 |
| 159 |
SKIN WRINKLING |
2 |
0.0007 |
| 160 |
ULCERATIVE KERATITIS |
2 |
0.0007 |
| 161 |
NEOVASCULAR AGE-RELATED MACULAR DEGENERATION |
1 |
0.0007 |
| 162 |
AUDITORY DISORDER |
1 |
0.0007 |
| 163 |
INCORRECT DRUG ADMINISTRATION RATE |
3 |
0.0007 |
| 164 |
TENSION HEADACHE |
3 |
0.0007 |
| 165 |
NOROVIRUS INFECTION |
1 |
0.0007 |
| 166 |
SEBORRHOEIC KERATOSIS |
1 |
0.0007 |
| 167 |
GENERALISED ANXIETY DISORDER |
1 |
0.0007 |
| 168 |
PRECANCEROUS SKIN LESION |
1 |
0.0007 |
| 169 |
PHYSICAL DISABILITY |
3 |
0.0007 |
| 170 |
APRAXIA |
1 |
0.0007 |
| 171 |
EYE HAEMORRHAGE |
9 |
0.0007 |
| 172 |
CATARACT OPERATION |
4 |
0.0007 |
| 173 |
GASTROINTESTINAL WALL THICKENING |
1 |
0.0007 |
| 174 |
HYPOSMIA |
1 |
0.0007 |
| 175 |
ASTIGMATISM |
1 |
0.0007 |
| 176 |
MASTICATION DISORDER |
2 |
0.0007 |
| 177 |
DEVICE PHYSICAL PROPERTY ISSUE |
5 |
0.0007 |
| 178 |
EYE ALLERGY |
1 |
0.0006 |
| 179 |
ONYCHOLYSIS |
1 |
0.0006 |
| 180 |
BACTERIAL VAGINOSIS |
1 |
0.0006 |
| 181 |
SKIN TIGHTNESS |
3 |
0.0006 |
| 182 |
OPHTHALMOPLEGIA |
1 |
0.0006 |
| 183 |
INHIBITORY DRUG INTERACTION |
1 |
0.0006 |
| 184 |
PHARYNGEAL PARAESTHESIA |
1 |
0.0006 |
| 185 |
GLYCOSYLATED HAEMOGLOBIN DECREASED |
1 |
0.0006 |
| 186 |
INCORRECT DOSAGE ADMINISTERED |
3 |
0.0006 |
| 187 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
43 |
0.0006 |
| 188 |
MEAN CELL HAEMOGLOBIN INCREASED |
1 |
0.0006 |
| 189 |
MADAROSIS |
7 |
0.0006 |
| 190 |
VEIN RUPTURE |
1 |
0.0006 |
| 191 |
ACUTE SINUSITIS |
1 |
0.0006 |
| 192 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 193 |
DIPLOPIA |
15 |
0.0006 |
| 194 |
SPONDYLOLISTHESIS |
1 |
0.0006 |
| 195 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 196 |
CONJUNCTIVAL HYPERAEMIA |
2 |
0.0006 |
| 197 |
EYE DISORDER |
18 |
0.0005 |
| 198 |
RETINAL DETACHMENT |
5 |
0.0005 |
| 199 |
AURA |
1 |
0.0005 |
| 200 |
PRODUCT STORAGE ISSUE |
2 |
0.0005 |
| 201 |
HYPOGEUSIA |
1 |
0.0005 |
| 202 |
CONCOMITANT DISEASE AGGRAVATED |
3 |
0.0005 |
| 203 |
CONJUNCTIVITIS |
9 |
0.0005 |
| 204 |
DEVICE MATERIAL ISSUE |
1 |
0.0005 |
| 205 |
INTRAOCULAR PRESSURE INCREASED |
6 |
0.0005 |
| 206 |
DRUG INEFFECTIVE |
618 |
0.0005 |
| 207 |
PRODUCT DISPENSING ISSUE |
2 |
0.0005 |
| 208 |
FACIAL PAIN |
4 |
0.0004 |
| 209 |
SINUS PAIN |
1 |
0.0004 |
| 210 |
FEELING JITTERY |
8 |
0.0004 |
| 211 |
URINARY HESITATION |
1 |
0.0004 |
| 212 |
WRONG DOSE |
1 |
0.0004 |
| 213 |
PAROSMIA |
3 |
0.0004 |
| 214 |
EXPIRED PRODUCT ADMINISTERED |
13 |
0.0004 |
| 215 |
MEAN CELL VOLUME INCREASED |
1 |
0.0004 |
| 216 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
2 |
0.0004 |
| 217 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
1 |
0.0004 |
| 218 |
NASAL DISCOMFORT |
3 |
0.0004 |
| 219 |
ADVERSE REACTION |
5 |
0.0004 |
| 220 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 221 |
EAR CONGESTION |
1 |
0.0004 |
| 222 |
JAW DISORDER |
2 |
0.0004 |
| 223 |
MACULAR OEDEMA |
2 |
0.0004 |
| 224 |
STRABISMUS |
1 |
0.0003 |
| 225 |
MACULAR DEGENERATION |
4 |
0.0003 |
| 226 |
IRITIS |
1 |
0.0003 |
| 227 |
KERATITIS |
1 |
0.0003 |
| 228 |
BLOOD PRESSURE INCREASED |
50 |
0.0003 |
| 229 |
BLOOD BLISTER |
1 |
0.0003 |
| 230 |
IRIDOCYCLITIS |
1 |
0.0003 |
| 231 |
HEADACHE |
197 |
0.0003 |
| 232 |
SUBSTANCE USE DISORDER |
1 |
0.0003 |
| 233 |
CARDIAC FLUTTER |
2 |
0.0003 |
| 234 |
VULVOVAGINAL DRYNESS |
1 |
0.0003 |
| 235 |
DEAFNESS NEUROSENSORY |
1 |
0.0003 |
| 236 |
INFUSION SITE HAEMORRHAGE |
1 |
0.0003 |
| 237 |
POTENTIATING DRUG INTERACTION |
1 |
0.0003 |
| 238 |
DRY THROAT |
3 |
0.0003 |
| 239 |
HEPATIC CYST |
1 |
0.0003 |
| 240 |
RETINAL HAEMORRHAGE |
2 |
0.0003 |
| 241 |
SWELLING FACE |
18 |
0.0003 |
| 242 |
BLOOD PHOSPHORUS DECREASED |
1 |
0.0003 |
| 243 |
FEELING DRUNK |
2 |
0.0003 |
| 244 |
HYPOAESTHESIA ORAL |
4 |
0.0003 |
| 245 |
CHEMOTHERAPY |
1 |
0.0003 |
| 246 |
THYROID MASS |
1 |
0.0003 |
| 247 |
OPTIC ISCHAEMIC NEUROPATHY |
1 |
0.0003 |
| 248 |
BLOOD PRESSURE SYSTOLIC INCREASED |
5 |
0.0003 |
| 249 |
MIGRAINE |
24 |
0.0003 |
| 250 |
MYASTHENIA GRAVIS |
2 |
0.0002 |
| 251 |
ENURESIS |
1 |
0.0002 |
| 252 |
FRUSTRATION TOLERANCE DECREASED |
2 |
0.0002 |
| 253 |
PERIPHERAL VENOUS DISEASE |
1 |
0.0002 |
| 254 |
SENSATION OF FOREIGN BODY |
2 |
0.0002 |
| 255 |
TONGUE DISCOMFORT |
1 |
0.0002 |
| 256 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 257 |
FACIAL PARALYSIS |
2 |
0.0002 |
| 258 |
SKIN SWELLING |
2 |
0.0002 |
| 259 |
ORTHOSTATIC HYPOTENSION |
4 |
0.0002 |
| 260 |
MELANOCYTIC NAEVUS |
1 |
0.0002 |
| 261 |
OFF LABEL USE |
199 |
0.0002 |
| 262 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
1 |
0.0002 |
| 263 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 264 |
LUMBAR VERTEBRAL FRACTURE |
1 |
0.0002 |
| 265 |
VISUAL IMPAIRMENT |
27 |
0.0002 |
| 266 |
SEASONAL ALLERGY |
3 |
0.0002 |
| 267 |
PHARYNGEAL SWELLING |
2 |
0.0002 |
| 268 |
BREATH SOUNDS ABNORMAL |
1 |
0.0002 |
| 269 |
ECONOMIC PROBLEM |
3 |
0.0002 |
| 270 |
EAR DISCOMFORT |
2 |
0.0002 |
| 271 |
TRISMUS |
1 |
0.0002 |
| 272 |
PRODUCT ODOUR ABNORMAL |
2 |
0.0002 |
| 273 |
NYSTAGMUS |
1 |
0.0002 |
| 274 |
PALPITATIONS |
22 |
0.0002 |
| 275 |
PRODUCT RESIDUE PRESENT |
1 |
0.0002 |
| 276 |
MUSCLE TIGHTNESS |
3 |
0.0002 |
| 277 |
TIC |
1 |
0.0002 |
| 278 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 279 |
PHOTOSENSITIVITY REACTION |
3 |
0.0002 |
| 280 |
HYPERKERATOSIS |
1 |
0.0002 |
| 281 |
REBOUND EFFECT |
2 |
0.0002 |
| 282 |
DERMATITIS CONTACT |
2 |
0.0002 |
| 283 |
CORONARY ARTERY BYPASS |
1 |
0.0002 |
| 284 |
HERPES VIRUS INFECTION |
1 |
0.0002 |
| 285 |
RHINORRHOEA |
11 |
0.0002 |
| 286 |
ENERGY INCREASED |
1 |
0.0002 |
| 287 |
TYPE 1 DIABETES MELLITUS |
1 |
0.0002 |
| 288 |
ACCIDENTAL OVERDOSE |
6 |
0.0002 |
| 289 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 290 |
SOMNAMBULISM |
1 |
0.0002 |
| 291 |
DISABILITY |
3 |
0.0002 |
| 292 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 293 |
HEART RATE INCREASED |
15 |
0.0002 |
| 294 |
SKIN MASS |
1 |
0.0001 |
| 295 |
MENINGITIS |
1 |
0.0001 |
| 296 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 297 |
SINUS CONGESTION |
2 |
0.0001 |
| 298 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 299 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 300 |
BLINDNESS UNILATERAL |
2 |
0.0001 |
| 301 |
THERMAL BURN |
1 |
0.0001 |
| 302 |
IMPAIRED QUALITY OF LIFE |
2 |
0.0001 |
| 303 |
PARAESTHESIA ORAL |
2 |
0.0001 |
| 304 |
PANIC REACTION |
1 |
0.0001 |
| 305 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 306 |
RASH PRURITIC |
7 |
0.0001 |
| 307 |
BRAIN FOG |
2 |
0.0001 |
| 308 |
RENAL CYST |
1 |
0.0001 |
| 309 |
INTENTIONAL PRODUCT MISUSE |
11 |
0.0001 |
| 310 |
STENT PLACEMENT |
1 |
0.0001 |
| 311 |
PRESYNCOPE |
3 |
0.0001 |
| 312 |
DECUBITUS ULCER |
1 |
0.0001 |
| 313 |
BLINDNESS |
5 |
0.0001 |
| 314 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 315 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 316 |
THERAPEUTIC RESPONSE SHORTENED |
4 |
0.0001 |
| 317 |
DRUG USE DISORDER |
1 |
0.0001 |
| 318 |
DIZZINESS |
59 |
0.0001 |
| 319 |
CATARACT |
7 |
0.0001 |
| 320 |
HYPOPHAGIA |
3 |
0.0001 |
| 321 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 322 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
0.0001 |
| 323 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 324 |
MUSCLE STRAIN |
1 |
0.0001 |
| 325 |
DEVICE USE ISSUE |
2 |
0.0001 |
| 326 |
THERAPEUTIC RESPONSE UNEXPECTED |
5 |
0.0001 |
| 327 |
DRY MOUTH |
9 |
0.0001 |
| 328 |
LIP DRY |
1 |
0.0001 |
| 329 |
SKIN DISCOLOURATION |
5 |
0.0001 |
| 330 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 331 |
BLOOD GLUCOSE ABNORMAL |
2 |
0.0001 |
| 332 |
HYPERSENSITIVITY |
20 |
0.0001 |
| 333 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 334 |
INCREASED APPETITE |
2 |
0.0001 |
| 335 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 336 |
TASTE DISORDER |
2 |
0.0001 |
| 337 |
DISCOMFORT |
6 |
0.0001 |
| 338 |
SLUGGISHNESS |
1 |
0.0001 |
| 339 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 340 |
LIMB DISCOMFORT |
3 |
0.0001 |
| 341 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 342 |
TENDERNESS |
1 |
0.0001 |
| 343 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 344 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 345 |
SKIN LACERATION |
1 |
0.0001 |
| 346 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 347 |
OESOPHAGITIS |
1 |
0.0001 |
| 348 |
NECK PAIN |
5 |
0.0001 |
| 349 |
SNEEZING |
2 |
0.0001 |
| 350 |
PRODUCT USE IN UNAPPROVED INDICATION |
22 |
0.0001 |
| 351 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 352 |
SCAB |
1 |
0.0001 |
| 353 |
TINNITUS |
4 |
0.0001 |
| 354 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 355 |
SPINAL PAIN |
1 |
0.0001 |
| 356 |
NASAL CONGESTION |
5 |
0.0001 |
| 357 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 358 |
BURSITIS |
1 |
0.0001 |
| 359 |
FIBROMYALGIA |
2 |
0.0001 |
| 360 |
VERTIGO |
5 |
0.0001 |
| 361 |
TENDON RUPTURE |
1 |
0.0001 |
| 362 |
DYSGEUSIA |
6 |
0.0001 |
| 363 |
CYST |
1 |
0.0001 |
| 364 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 365 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 366 |
CHEST DISCOMFORT |
8 |
0.0001 |
| 367 |
ADVERSE EVENT |
7 |
0.0001 |
| 368 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 369 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 370 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 371 |
PAIN OF SKIN |
2 |
0.0001 |
| 372 |
DISTURBANCE IN ATTENTION |
4 |
0.0001 |
| 373 |
UVEITIS |
1 |
0.0001 |
| 374 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 375 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 376 |
URTICARIA |
12 |
0.0001 |
| 377 |
SKIN REACTION |
1 |
0.0001 |
| 378 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 379 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0001 |
| 380 |
TACHYCARDIA |
6 |
0.0001 |
| 381 |
ADVERSE DRUG REACTION |
6 |
0.0001 |
| 382 |
SKIN IRRITATION |
3 |
0.0001 |
| 383 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 384 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 385 |
LIP SWELLING |
2 |
0.0001 |
| 386 |
URINARY RETENTION |
2 |
0.0001 |
| 387 |
PRODUCT USE ISSUE |
11 |
0.0001 |
| 388 |
INTENTIONAL PRODUCT USE ISSUE |
5 |
0.0001 |
| 389 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 390 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 391 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
3 |
0.0001 |
| 392 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 393 |
ERYTHEMA |
11 |
0.0001 |
| 394 |
FOOT FRACTURE |
1 |
0.0001 |
| 395 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 396 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 397 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 398 |
EAR PAIN |
1 |
0.0001 |
| 399 |
PARAESTHESIA |
8 |
0.0001 |
| 400 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 401 |
EXTRA DOSE ADMINISTERED |
2 |
0.0000 |
| 402 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 403 |
SKIN EXFOLIATION |
4 |
0.0000 |
| 404 |
RETCHING |
1 |
0.0000 |
| 405 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 406 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 407 |
SKIN CANCER |
1 |
0.0000 |
| 408 |
BALANCE DISORDER |
4 |
0.0000 |
| 409 |
CONDITION AGGRAVATED |
14 |
0.0000 |
| 410 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 411 |
PRODUCT STORAGE ERROR |
4 |
0.0000 |
| 412 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 413 |
RASH PAPULAR |
1 |
0.0000 |
| 414 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 415 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 416 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 417 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 418 |
INJURY |
3 |
0.0000 |
| 419 |
DYSPHAGIA |
4 |
0.0000 |
| 420 |
BLOOD GLUCOSE DECREASED |
2 |
0.0000 |
| 421 |
EMOTIONAL DISTRESS |
5 |
0.0000 |
| 422 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 423 |
NEURALGIA |
1 |
0.0000 |
| 424 |
EPISTAXIS |
3 |
0.0000 |
| 425 |
HOT FLUSH |
3 |
0.0000 |
| 426 |
CELLULITIS |
2 |
0.0000 |
| 427 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 428 |
INCORRECT DOSE ADMINISTERED |
9 |
0.0000 |
| 429 |
PRURITUS |
15 |
0.0000 |
| 430 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 431 |
NERVOUSNESS |
2 |
0.0000 |
| 432 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 433 |
HYPERTENSION |
8 |
0.0000 |
| 434 |
INSOMNIA |
10 |
0.0000 |
| 435 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 436 |
LIMB INJURY |
1 |
0.0000 |
| 437 |
PALLOR |
1 |
0.0000 |
| 438 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 439 |
FEELING COLD |
1 |
0.0000 |
| 440 |
WOUND |
1 |
0.0000 |
| 441 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 442 |
PAIN IN JAW |
1 |
0.0000 |
| 443 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 444 |
LETHARGY |
2 |
0.0000 |
| 445 |
DYSSTASIA |
1 |
0.0000 |
| 446 |
DYSPHONIA |
2 |
0.0000 |
| 447 |
CHILLS |
4 |
0.0000 |
| 448 |
MALAISE |
14 |
0.0000 |
| 449 |
ANXIETY |
9 |
0.0000 |
| 450 |
HEAD INJURY |
1 |
0.0000 |
| 451 |
INTENTIONAL OVERDOSE |
2 |
0.0000 |
| 452 |
HIP FRACTURE |
1 |
0.0000 |
| 453 |
HYPERHIDROSIS |
4 |
0.0000 |
| 454 |
NIGHT SWEATS |
1 |
0.0000 |
| 455 |
AMNESIA |
2 |
0.0000 |
| 456 |
BLOOD CREATININE INCREASED |
2 |
0.0000 |
| 457 |
IMPAIRED HEALING |
1 |
0.0000 |
| 458 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 459 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 460 |
SYNCOPE |
3 |
0.0000 |
| 461 |
SKIN DISORDER |
1 |
0.0000 |
| 462 |
ABDOMINAL DISCOMFORT |
5 |
0.0000 |
| 463 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 464 |
ILLNESS |
3 |
0.0000 |
| 465 |
NAUSEA |
23 |
0.0000 |
| 466 |
HEART RATE DECREASED |
1 |
0.0000 |
| 467 |
RASH |
12 |
0.0000 |
| 468 |
CRYING |
1 |
0.0000 |
| 469 |
HYPOAESTHESIA |
4 |
0.0000 |
| 470 |
DYSARTHRIA |
1 |
0.0000 |
| 471 |
DISORIENTATION |
1 |
0.0000 |
| 472 |
WEIGHT DECREASED |
7 |
0.0000 |
| 473 |
HYPOTENSION |
5 |
0.0000 |
| 474 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
5 |
0.0000 |
| 475 |
DYSKINESIA |
1 |
0.0000 |
| 476 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 477 |
TREMOR |
4 |
0.0000 |
| 478 |
ASTHENIA |
9 |
0.0000 |
| 479 |
HYPOACUSIS |
1 |
0.0000 |
| 480 |
SEPTIC SHOCK |
1 |
0.0000 |
| 481 |
DEHYDRATION |
3 |
0.0000 |
| 482 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 483 |
THROAT IRRITATION |
1 |
0.0000 |
| 484 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 485 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 486 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 487 |
ARRHYTHMIA |
1 |
0.0000 |
| 488 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 489 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 490 |
FEELING ABNORMAL |
5 |
0.0000 |
| 491 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 492 |
CONTUSION |
2 |
0.0000 |
| 493 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 494 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 495 |
FLUID RETENTION |
1 |
0.0000 |
| 496 |
SINUSITIS |
2 |
0.0000 |
| 497 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 498 |
SPEECH DISORDER |
1 |
0.0000 |
| 499 |
BRADYCARDIA |
1 |
0.0000 |
| 500 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 501 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 502 |
PAIN |
11 |
0.0000 |
| 503 |
HYPONATRAEMIA |
1 |
0.0000 |
| 504 |
BONE PAIN |
1 |
0.0000 |
| 505 |
IRRITABILITY |
1 |
0.0000 |
| 506 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 507 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 508 |
MUSCLE SPASMS |
3 |
0.0000 |
| 509 |
FEELING HOT |
1 |
0.0000 |
| 510 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 511 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 512 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 513 |
FALL |
5 |
0.0000 |
| 514 |
DRY SKIN |
2 |
0.0000 |
| 515 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 516 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 517 |
BURNING SENSATION |
1 |
0.0000 |
| 518 |
SLEEP DISORDER |
1 |
0.0000 |
| 519 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 520 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 521 |
BRONCHITIS |
1 |
0.0000 |
| 522 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 523 |
BACK PAIN |
3 |
0.0000 |
| 524 |
VOMITING |
6 |
0.0000 |
| 525 |
ARTHRITIS |
1 |
0.0000 |
| 526 |
DRUG INTERACTION |
2 |
0.0000 |
| 527 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 528 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 529 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 530 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 531 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 532 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 533 |
COVID-19 |
2 |
0.0000 |
| 534 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 535 |
DEVICE ISSUE |
1 |
0.0000 |
| 536 |
DIARRHOEA |
7 |
0.0000 |
| 537 |
COUGH |
3 |
0.0000 |
| 538 |
DYSPNOEA |
6 |
0.0000 |
| 539 |
FATIGUE |
8 |
0.0000 |
| 540 |
DYSPEPSIA |
1 |
0.0000 |
| 541 |
FLUSHING |
1 |
0.0000 |
| 542 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 543 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 544 |
CONSTIPATION |
2 |
0.0000 |
| 545 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 546 |
WEIGHT INCREASED |
2 |
0.0000 |
| 547 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 548 |
DEPRESSION |
2 |
0.0000 |
| 549 |
PYREXIA |
3 |
0.0000 |
| 550 |
DECREASED APPETITE |
2 |
0.0000 |
| 551 |
JOINT SWELLING |
1 |
0.0000 |
| 552 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 553 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 554 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 555 |
MYALGIA |
1 |
0.0000 |
| 556 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 557 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 558 |
ANAEMIA |
1 |
0.0000 |
| 559 |
ALOPECIA |
1 |
0.0000 |
| 560 |
SOMNOLENCE |
1 |
0.0000 |
| 561 |
ARTHRALGIA |
2 |
0.0000 |
| 562 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 563 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 564 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 565 |
DEATH |
1 |
0.0000 |